| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―31 |
Negative prognostic associations of selective serotonin reuptake inhibitors use in hospitalized COVID-19 patients and potential contribution of cardiovascular comorbidities |
Ivan Papic, Petra Bistrovic, Ivan Krecak, Maja Ortner Hadziabdic, Marko Lucijanic |
| 2 |
[GO] |
2021―Sep―16 |
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19 |
Mangaldeep Dey, Rakesh Kumar Singh |
| 3 |
[GO] |
2021―Aug―10 |
Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic |
Huda R. Taha, Nour Keewan, Farah Slati, Nour A. Al-Sawalha |
| 4 |
[GO] |
2021―Apr―29 |
Utilizing Artificial Intelligence to Manage COVID-19 Scientific Evidence Torrent with Risklick AI: A Critical Tool for Pharmacology and Therapy Development |
Quentin Haas, David Vicente Alvarez, Nikolay Borissov, Sohrab Ferdowsi, Leonhard von Meyenn, Sven Trelle, et al. (+2) Douglas Teodoro, Poorya Amini |
| 5 |
[GO] |
2020―Oct―02 |
SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19? |
Morteza Ghasemnejad-Berenji, Sarvin Pashapour |
